Larry has a deep understanding of what drives government enforcement actions, and how to defend against them, in the health care and life sciences industries. As a trial lawyer and then official in the Civil Fraud Section of the U.S. Department of Justice, he litigated and supervised hundreds of False Claims Act and qui tam cases nationally. In his litigation practice, Larry has successfully represented hospitals and health care systems, laboratories, pharmaceutical and device manufacturers, and health care executives against fraud and abuse allegations and investigations brought by federal and state agencies. He is consistently recognized among the nation’s leading health care defense attorneys.

Larry’s health care and life sciences litigation practice focuses on defending clients against allegations and investigations of fraud and abuse involving governmental programs. He is highly experienced in representing clients against actions brought by federal and state agencies including the US Department of Justice (DOJ), the Department of Health and Human Services Office of the Inspector General (HHS OIG), the United States Attorneys’ Offices, and state OIGs and Medicaid Fraud Control Units (MFCUs).

Larry’s practice is based on his 24-years of experience handling complex civil litigation, often in the context of parallel proceedings, and achieving global resolutions. In addition to enforcement defense, Larry counsels clients through internal investigations, corporate compliance, investor due diligence reviews, and health care bankruptcies involving governmental liabilities. His clients include hospitals and health systems, dialysis providers, clinical laboratories, medical equipment companies, pharmaceutical and device manufacturers, and health care executives.

Prior to private practice, Larry served as an Assistant Director with the Civil Fraud Section of the DOJ and focused solely on the False Claims Act and its qui tam provisions. At DOJ he supervised hundreds of qui tam cases filed in US district courts throughout the country, was part of the leadership team for the pharmaceutical enforcement initiative, and managed high-profile actions often involving multiple US Attorneys’ Offices and federal agencies.

Prior to his position as Assistant Director, Larry served with the Civil Fraud Section as a trial attorney focused on health care fraud and defense procurement. He co-led the notable investigation and prosecution of national independent clinical laboratories known as “Operation LABSCAM.” For his achievements, Larry was highly-recognized by the Attorney General with the Department’s highest and second highest awards, as well as multiple awards from the HHS OIG and the MFCUs.

Following law school, Larry served as a law clerk for the Honorable Richard Cardamone of the U.S. Court of Appeals for the Second Circuit.

Represent a major national “Part D” Plan Sponsor in declined qui tam litigations in the Southern District of New York and the District of Rhode Island regarding alleged industry-wide fraud in “Direct and Indirect Remuneration” reporting to CMS.
Represent a national testing laboratory in a False Claims Act investigation and qui tam matter regarding relationships with hospital-clients, and part of teams representing numerous genetic testing clinical laboratories in qui tam investigations and settlements.
Represented a $1B urban health care system in a DOJ criminal and civil investigation involving allegations of violations of the Anti-Kickback Statute and Stark Laws with respect to physician compensation, and successfully reached a comprehensive civil settlement.
Represented a CEO of major Medicaid managed care company with respect to alleged fraud involving Medicaid “medical loss ratio” reporting.
Represented leading solar distributed power company in False Claims Act investigation involving alleged fraud in connection with U.S. Treasury “1603” program of grants in lieu of tax credits.
Represented as settlement counsel Tuomey Hospital in its False Claims Act and Stark Law litigation involving physician compensation, and successfully resolved all allegations against it after two trials and appeals.
Represented a health care system with respect to its only known administrative proceeding by CMS alleging Stark Law violations, and successfully resolved allegations without any liability.
Represented national dialysis company with respect to a qui tam matter and high-profile internal investigation and whistleblower matters.
Represented the United States as a DOJ official with respect to hundreds of qui tam actions nationally alleging fraud by hospitals and health systems, clinical laboratories, post-acute providers, dialysis companies, and others with respect to allegations under the False Claims Act, Anti-Kickback Statute, Stark Law, and related criminal and civil enforcement laws.

Read less

Health Care Enforcement Year-in-Review and 2020 Outlook: Civil Fraud Enforcement Developments and Trends

January 21, 2020 | Blog | By Brian Dunphy, Laurence Freedman, Karen Lovitch , Nicole Henry, Clare Prober

As discussed in our article recently published by Law360, 2019 brought yet another year of robust health care enforcement activity, and the False Claims Act (FCA) remains the government’s most powerful civil health care enforcement tool. This post will give an overview of our article, which covers these issues and more in great detail.

September 11, 2019 | Blog | By Samantha Kingsbury, Laurence Freedman, Brian Dunphy

On Monday, the U.S. Court of Appeals for the Eleventh Circuit issued its long-awaited and closely watched decision in United States v. AseraCare Inc.. The court ruled that a claim cannot be deemed false under the False Claims Act (FCA) based on a difference in clinical judgment. Instead, there must be proof of an objective falsehood. More than three years have passed since the U.S. District Court for the Northern District of Alabama issued the series of rulings that gave rise to the Eleventh Circuit case.

June 25, 2019 | Blog | By Samantha Kingsbury, Laurence Freedman

Over the last two years, much of the healthcare world has been watching the government’s prosecution of Insys Therapeutics for its sales and marketing practices related to its Subsys spray. Subsys is powerful and highly addictive fentanyl spray (administered under the tongue) that was approved by the FDA in 2012 for the treatment of persistent breakthrough pain in adult cancer patients who were already receiving, and tolerant to, regular opioid therapy. On June 5, 2019, DOJ announced a global resolution with Insys, including criminal pleas, a Deferred Prosecution Agreement (DPA), a civil settlement agreement, and a Corporate Integrity Agreement (CIA). Then, on June 10, 2019, Insys filed for bankruptcy protection, which triggered DOJ and HHS’s ability to upend these agreements and impose powerful criminal, civil, and exclusion remedies against Insys. While much of the coverage of this case over the last few years has focused on the high-profile prosecution and conviction of company executives (including Insys’s founder) and other employees who were accused of paying kickbacks to prescribers in exchange for increased prescriptions and increased doses of Subsys, the resolution of this case on the corporate side has proven to be equally fascinating.

June 4, 2019 | Blog | By Laurence Freedman, Daryl Berke

On June 3, 2019, the U.S. Supreme Court issued a decision in Azar v. Allina Health Services. The case involved a challenge by hospitals over whether the Department of Health and Human Services (“HHS”) was required to proceed through notice-and-comment rulemaking before promulgating a retroactive Medicare rate calculation methodology for Disproportionate Share (DSH) payments to hospitals. In a 7-1 decision by Justice Gorsuch, the Court ruled in favor of the hospitals, holding that the new rate calculation established a substantive legal standard, and therefore notice-and-comment was required under the Medicare Act.

May 10, 2019 | Blog | By Jane Haviland, Laurence Freedman

The U.S. Department of Justice (DOJ) issued policy guidance on May 6, 2019, about providing credit in False Claims Act (FCA) settlements to corporations for “disclosure, cooperation, and remediation." DOJ has never previously issued guidance regarding credit in FCA matters. This guidance, coupled with the passage of the Tax Cuts and Jobs Act in 2017 (which requires DOJ to specify the amount of “restitution” or “remediation” at the time of settlement), provides meaningful specificity as to what conduct constitutes disclosure, cooperation, and remediation, as well as data for evaluating whether credit is actually reflected in negotiated FCA settlements. This policy guidance is contained in the Justice Manual, Section 4-4.112.

February 4, 2019 | Blog | By Laurence Freedman, Daryl Berke

On January 15, 2019, the Supreme Court heard oral arguments in Azar v. Allina Health Services, a prominent case involving a challenge by hospitals over when Medicare’s instructions to its contractors impact a “substantive legal standard” and thus must be issued through formal rulemaking. As discussed in our prior post, the Court is reviewing the U.S. Court of Appeals for the D.C. Circuit’s decision that threw out a Medicare rate calculation methodology for Disproportionate Share Payments (DSH) to hospitals adopted by the U.S. Department of Health and Human Services (HHS) for its failure to undergo notice and comment rulemaking. During oral arguments, the Court grappled with a broader question: what is the legal standard for when HHS must use formal rulemaking and not “interpretative” instructions to its contractors in the administration of the Medicare program?

January 14, 2019 | Blog | By Laurence Freedman, Daryl Berke

On January 15, 2019, the U.S. Supreme Court will hear arguments in a hotly-contested case involving a challenge by hospitals over when Medicare’s instructions to its contractors impact a “substantive legal standard” and thus must be issued through formal rulemaking. In Azar v. Allina Health Services, the Court will review the U.S. Court of Appeals for the D.C. Circuit’s decision that threw out a new Medicare rate calculation methodology for Disproportionate Share Payments (DSH) to hospitals adopted by the U.S. Department of Health and Human Services (HHS) because the agency promulgated it through “interpretative guidance” but failed to undergo notice-and-comment rulemaking. The Supreme Court is now tasked with answering a broader question: what is the legal standard for when HHS must use formal rulemaking and not “interpretative” instructions to its contractors in the administration of the Medicare program?

January 11, 2019 | Blog | By Brian Dunphy, Laurence Freedman, Karen Lovitch

As in years past, the False Claims Act (FCA) remained a powerful health care enforcement tool in 2018, and FCA investigations and litigation persisted, fueled mainly by hundreds of lawsuits filed annually by relators, including 645 new qui tam actions initiated in FY 2018.

January 10, 2019 | Blog | By Brian Dunphy, Laurence Freedman

Last year, as we previously discussed, there were two significant Department of Justice (DOJ) policy developments that are applicable to False Claims Act (FCA) litigation: (1) the “Granston Memo” (issued by DOJ Civil Fraud Director Michael Granston), which set forth direction for DOJ’s exercise of its authority to dismiss declined qui tam FCA cases; and (2) the “Brand Memo” (issued by Associate Attorney General Rachel Brand), which instructed DOJ’s FCA litigators not to use any sub-regulatory guidance to create legal obligations.

December 20, 2018 | Blog | By Laurence Freedman, Bridgette Keller

Along with most of us, last January DOJ set its own goals for 2018: new policies related to False Claims Act (“FCA”) enforcement. One such “resolution” for 2018 was the DOJ Civil Fraud section’s instruction to its attorneys and all AUSAs handling FCA cases to routinely consider whether declined qui tam actions should be dismissed under the Department’s authority in Section 3730(c)(2)(A) of the FCA, which it had rarely used from 1986 through 2017. Known as the “Granston Memo” (which we discuss here) and now codified in the Justice Manual, the central theme of the instruction is that seeking dismissal of qui tam actions may be in the government’s interest to “preserve limited resources and avoid adverse precedent.” We are now seeing the first evidence of DOJ following through on that resolution.

Read less

FCA Settlements Demonstrate Importance of Cybersecurity Controls Imposed by Contract

August 20, 2024

Members Scott Lashway, Laurence Freedman, and Special Counsel Matthew Stein published an article in Bloomberg Law about how recent False Claims Act (FCA) settlements show a focus on cybersecurity enforcement. In the article, they outline how organizations with government contracts can mitigate the risk of cybersecurity-related FCA investigations and litigation.

The Best Lawyers in America 2025 Recognizes 184 Mintz Attorneys across 56 Practice Areas

August 15, 2024

187 Mintz attorneys have been recognized by Best Lawyers® in the 2025 edition of The Best Lawyers in America©. Notably, three Mintz attorneys received 2025 “Lawyer of the Year” awards, and 64 firm attorneys were included in the 2025 edition of Best Lawyers: Ones to Watch.

Chambers USA Ranks 83 Individual Attorneys and 42 Mintz Practices

June 06, 2024

Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.

Mintz Attorneys Recognized as 2024 Washington DC Super Lawyers and Rising Stars

April 22, 2024

One Hundred Twenty Mintz Attorneys Ranked as Leaders by Best Lawyers 2024

August 17, 2023

Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.

Chambers USA Ranks 39 Mintz Practices and 81 Individual Attorneys

June 01, 2023

BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.

50 Years In, Industry Has Knives Out For Potent Kickback Law

March 18, 2023

Member Laurence J. Freedman spoke to Law360 about the growing challenges with the Anti-Kickback Statute.

HHS Pans Pfizer's 'Far-Fetched' Kickback Views At High Court

December 14, 2022

Mintz Member Laurence J. Freedman spoke to Law360 about the awaited brief from the U.S. Department of Health and Human Services on whether Anti-Kickback Statute cases should show whether health care "remuneration" intentionally impacted medical decision making.

A Circuit-By-Circuit Guide To FCA Suits After High Court Snub

November 1, 2022

Mintz Member Laurence Freedman was quoted in a Law360 article exploring the U.S. Supreme Court's refusal to resolve one of the False Claims Act's most consequential controversies and how this is causing a divide in circuit courts.

One Hundred Eight Mintz Attorneys Ranked as Leaders by Best Lawyers 2023

August 18, 2022

Best Lawyers® recognized 108 firm attorneys in the 2023 edition of The Best Lawyers in America©. Notably, two Mintz attorneys – Poonam Patidar and Scott M. Stanton – received 2023 “Lawyer of the Year” awards, and 28 firm attorneys were included in the inaugural edition of Best Lawyers: Ones to Watch.

Eighty-three Mintz Attorneys And 34 Practices Recognized in Chambers USA 2022

June 01, 2022

Healthcare Enforcement & Litigation 2022

August 27, 2021

Mintz Member and Chair of the firm’s Health Law and Health Care Enforcement Defense Practices Karen Lovitch, Member Laurence Freedman, Of Counsel Samantha Kingsbury, and Associates Grady Campion and Caitlin Hill co-authored the Global Overview and corresponding United States chapter of the seventh edition of Lexology’s Healthcare Enforcement & Litigation 2022. Together these pieces outlined federal enforcement priorities in 2020, including matters involving opioids, COVID-19-related fraud, Medicare, and more, and look ahead to how health care enforcement is expected to evolve in the coming year.

One Hundred Six Mintz Attorneys Ranked as Leaders by Best Lawyers 2022

August 19, 2021

Sixty-Nine Mintz Attorneys and 19 Practices Recognized by Chambers USA 2021

May 20, 2021

One Hundred Ten Mintz Attorneys Ranked as Leaders by Best Lawyers 2021

August 20, 2020

Mintz Attorneys and Practices Recognized by Chambers USA 2020

April 24, 2020

Ten Mintz Attorneys Honored as 2020 Washington, D.C. Super Lawyers and Rising Stars

April 16, 2020

FCA's Epic Run In 2010s Will Be Hard To Match In 2020s

January 29, 2020

In a January 24 article published by Law360, Mintz Member Laurence J. Freedman commented on a reported plateau in filings and recoveries from cases involving the False Claims Act (FCA). In the article, he noted that “any decrease in [qui tam] filings will not affect recoveries down the road.” If the U.S. Department of Justice (DOJ)’s willingness to dismiss declined cases or the Escobar materiality standard has discouraged filings, these qui tams likely “would have been cases without fraud that would have wasted government resources to investigate."

2019 Trends In DOJ Civil Health Care Fraud Cases

January 15, 2020

Mintz Members Brian Dunphy and Laurence Freedman, and Member and Co-Chair of the firm’s Health Law Practice Karen Lovitch co-authored this Law360 expert analysis article examining trends in U.S. Department of Justice health care enforcement in 2019, noting that the False Claims Act remains the government’s most powerful civil health care enforcement tool.

One Hundred Mintz Attorneys Ranked as Leaders by Best Lawyers 2020

August 15, 2019

FCA Challenge Poses 2 Potential Questions For Justices

May 6, 2019

Member Laurence Freedman provides analysis on recent development, legal questions raised thus far, and what’s at stake in the Supreme Court's recent interest in the Intermountain Healthcare Inc. FCA case.

Mintz Recognized by Chambers USA 2019

April 26, 2019

Thirteen Mintz Attorneys Named Washington, D.C. Super Lawyers and Rising Stars

April 23, 2019

Supreme Court Eyes Hospital Giant's FCA Case

February 25, 2019

This feature story discusses a False Claims Act case that has interested in Supreme Court which centers upon a hospital system’s challenging of the FCA’s constitutionality. The case further accuses the Tenth Circuit of improperly letting whistleblowers pursue cases with scant details. Mintz Member Larry Freedman is among the industry sources quoting providing commentary.

Eighty-Nine Mintz Attorneys Included in the Best Lawyers in America, 2019 Edition

August 15, 2018

Justices Search for Limits of False Claims Act Liability

April 27, 2018

Mintz Member Larry Freedman is quoted in this Bloomberg BNA Health Care Daily Report article on Supreme Court Justices’ search for a decision on the limits of FCA liability “when a claim for payment is submitted to the government for a service that doesn’t comply with all applicable regulations.”

Eleven Mintz Attorneys Named Washington, D.C. Super Lawyers and Rising Stars

April 24, 2018

Mintz is pleased to announce that eight attorneys have been named Washington, D.C. Super Lawyers for 2018 and three others have been named Washington, D.C. Rising Stars. The annual publication identifies lawyers who have attained a high degree of peer recognition and professional achievement.

DOJ Says Guidance Documents Can’t Drive Enforcement Actions

January 26, 2018

Mintz Member Larry Freedman was quoted in Bloomberg Law about a new policy from the Justice Department that prevents guidance documents from being used as a basis for bringing civil enforcement actions. It may lessen the risk of catastrophic punitive damages, particularly in False Claims Act cases.

Attys React To DOJ's New Memo On FCA Dismissals

January 25, 2018

Larry Freedman was quoted in a Law 360 article regarding a new Justice Department policy that prevents guidance documents from being used as a basis for bringing civil enforcement actions. The policy may lessen the risk of catastrophic punitive damages, particularly in False Claims Act cases.

2017 Health Care Enforcement Review: Materiality Under FCA

January 18, 2018

Larry Freedman and Jordan Cohen, both health care attorneys at Mintz, authored an article that was the third part of four in a series on health care enforcement trends in 2017. The series was published by Law360.

Eighty-Five Mintz Attorneys Included in the Best Lawyers in America, 2018 Edition

August 15, 2017

Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named “Lawyer of the Year” in their respective practice areas.

One Year Later, Escobar Is Roiling FCA Landscape

June 16, 2017

Larry Freedman, a health care and life sciences litigator and Member in the Mintz Washington, DC office, was quoted in this Law360 article on the impact of the U.S. Supreme Court’s Escobar decision one year earlier.

Twelve Mintz Attorneys Named 2017 Washington, D.C. Super Lawyers and Rising Stars

April 24, 2017

Eight Mintz attorneys have been named Washington, D.C. Super Lawyers for 2017 and four have been named Washington, D.C. Rising Stars. The list will be published in a special advertising supplement in The Washington Post Magazine and in a stand-alone magazine, Washington D.C. Super Lawyers Magazine.

Health Care Enforcement Review And 2017 Outlook: Part 3

January 18, 2017

This is the third installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.

Health Care Enforcement Review And 2017 Outlook: Part 2

January 17, 2017

Three attorneys from Mintz author the second installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.

Does Regulatory Compliance Matter in False Claims Act Cases?

December 29, 2016

Larry Freedman, a health care and life sciences litigator and Member in the Mintz Washington, DC office, was quoted in this Bloomberg BNA Health Care Blog piece on whether regulatory compliance matters in False Claims Act (FCA) cases.

Top Gov't Contracts Cases Of 2016

December 12, 2016

Larry Freedman, a litigator and Mintz Member, is quoted in this Law360 article covering some of the most important False Claims Act (FCA) or government contracts-related court decisions in 2016.

Justices Could Tip Power Balance In FCA Seal Dispute

October 31, 2016

U.S. Attorney Changes Mean Opportunities for Fraud Defendants

September 7, 2016

Larry Freedman, a health care and life sciences litigator and Mintz Member, is quoted in a Bloomberg BNA Health Care Fraud Report article on how current fraud investigations being conducted by U.S. attorneys could be impacted as the start of a new presidential administration approaches.

Seventy-Three Mintz Attorneys Included in The Best Lawyers in America, 2017 Edition

August 15, 2016

Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas.

Supreme Court term mixed bag for healthcare industry

July 3, 2016

Mintz Member Larry Freedman is quoted in this Modern Healthcare article discussing the mixed reactions to U.S. Supreme Court case outcomes related to the health care industry as their current term comes to a close.

Senate Finance Mulls Overhaul of Fraud Law

June 30, 2016

Mintz Washington, D.C. Member and health care and life sciences litigator Larry Freedman is quoted in this Bloomberg BNA Health Care Daily Report article on the Senate Finance consideration to overhaul fraud law.

Unanimous Supreme Court Sets Outer Limit on FCA Liability

June 17, 2016

Mintz Member Larry Freedman is quoted in this Bloomberg BNA Health Care Daily Report article on the U.S. Supreme Court ruling’s impact on False Claims Act liability in the Escobar case.

SCOTUS Goes Down Middle in False Claims Case

June 17, 2016

Mintz Member Larry Freedman is quoted in this MedPage Today article discussing the U.S. Supreme Court’s decision in the Universal Health Services v. United States ex rel. Escobar case.

Mintz Attorneys Thomas S. Crane and Laurence J. Freedman to Speak at National Institute on the Civil False Claims Act and Qui Tam Enforcement

June 03, 2016

DOJ Increasingly Demanding Corporate Cooperation in FCA Settlements After Yates Memo

May 26, 2016

Mintz Member Larry Freedman is quoted in this Bloomberg BNA Health Care Daily Report article on the Department of Justice’s increased pressure behind their demands for corporate cooperation in False Claims Act cases.

Eleven Mintz Attorneys Named 2016 Washington, D.C. Super Lawyers and Rising Stars

April 25, 2016

Health Fraud Defense Attys Riding High As Wins Pile Up

April 11, 2016

Mintz Members Larry Freedman and Chuck Samuels are quoted in this Law360 article on how the jury verdict in favor of Abbott Laboratories in its False Claims Act trial involving off-label marketing puts the defense bar on an official winning streak in these types of cases.

DOJ Aims Torpedo At FCA Sampling Suit In 4th Circ.

March 28, 2016

Mintz Member and health care litigator Larry Freedman is quoted in this Law360 article on the U.S. Department of Justice’s efforts to “avert an eagerly anticipated ruling” from the Fourth Circuit Court of Appeals on whether statistical sampling can be used to establish False Claims Act liability.

The Medicare Overpayment Rule: Implications for Compliance and Health Care Enforcement

February 26, 2016

Mintz Members Brian Dunphy and Larry Freedman authored this BNA’s Medicare Report article discussing the long-awaited final Medicare Overpayment Rule from the Centers for Medicare & Medicaid Services.

Lookback Period Cut to Six Years in Final Overpayments Rule

February 11, 2016

Larry Freedman, a Mintz Member, is quoted in this BNA’s Health Care Daily Report article on the final rule as it applies to Medicare overpayments, stating providers will “be responsible for reporting and returning all overpayments identified within six years of when the overpayment was received.”

Health Care Enforcement Reflections and Forecasts: Part 3

January 26, 2016

Mintz Members Hope Foster and Larry Freedman authored this Law360 column providing an overview of “some of the most important joint criminal and civil matters” impacting health care fraud enforcement from 2015 into 2016.

Health Care Enforcement Reflections and Forecasts: Part 2

January 25, 2016

Mintz Members Hope Foster and Larry Freedman authored this Law360 column, the second part in a three-part series, discussing some of the more notable cases and criminal prosecutions pertaining to health care enforcement in 2015.

Health Care Enforcement Reflections and Forecasts: Part 1

January 22, 2016

This column kicks off a three-part series from the Mintz Health Law team. Members Hope Foster and Larry Freedman authored this Law360 piece that recaps policy developments impacting fraud enforcement in 2015.

Health Care Cases to Watch in 2017

January 2, 2016

In this Law360 feature article, Larry provides commentary on the new guidelines for viability of False Claims Act cases after the Supreme Court’s ruling in Universal Health Services v. Escobar.

Mintz Attorney Laurence J. Freedman to Speak at HCCA Healthcare Enforcement Compliance Institute

October 21, 2015

Twenty-Two Mintz Attorneys and Seven Practice Areas Featured in 2015 Legal 500 United States Guide

June 11, 2015

Twelve Mintz Attorneys Named Washington, D.C. Super Lawyers and Rising Stars

April 17, 2015

Seven Mintz attorneys have been named Washington, D.C. Super Lawyers for 2015 and five have been named Washington, D.C. Rising Stars. The list will be published in a special advertising supplement in Washington Post Magazine and in a stand-alone Washington D.C. Super Lawyers Magazine.

Mintz Attorney Laurence J. Freedman to Speak at American Conference Institute’s Advanced Forum on Fraud & Abuse in the Sales and Marketing of Drugs

March 12, 2015

Mintz Attorney Laurence J. Freedman to Speak at American Bar Association’s 24th Annual National Institute on Health Care Fraud

May 14, 2014

Eleven Mintz Attorneys Named Washington, DC Super Lawyers and Rising Stars

April 25, 2014

Mintz Attorneys Christi J. Braun and Laurence J. Freedman to Speak at ABA’s 15th Annual Conference on Emerging Issues in Healthcare Law

February 24, 2014

Mintz Bolsters Health Care Enforcement Defense Capabilities With Addition of Former Senior DOJ Official

January 06, 2014

Read less

Speaker

Jun

2024

Handling Whistleblower Claims 2024 – Rights of Private Sector Employees

DC Bar CLE

Webinar

Jun

2023

Handling Whistleblower Claims 2022 - Rights of Private Sector Employees

DC Bar Continuing Legal Education

D.C. Bar, Washington, DC

Speaker

Nov

2022

Enforcement Liability and Insolvency and Bankruptcy

Health Care Compliance Association

Online Event

Jun

2022

Enforcement Liability & Bankruptcy/Insolvency

ABA 32nd Annual National Institute on Health Care Fraud

Caesars Palace

Speaker

Oct

2021

Releasing the 2021 False Claims Litigation Report

Lex Machina

Online Event

Panelist

Jun

2021

Handling Whistleblower Claims Series 2021 - Rights of Private Sector Employees

The District of Columbia Bar

Online Event

Speaker

May

2019

4th Annual Mintz /ML Strategies Pharmacy & Pharmaceutical Industry Summit

Mintz and ML Strategies

Boston, MA

Speaker

Jan

2019

Health Care Enforcement Year in Review & 2019 Outlook Webinar

Panelist

Nov

2018

HCCA's Healthcare Enforcement Compliance Conference

False Claims Act Developments

Washington, DC

Faculty

Jun

2018

Handling Whistleblower Claims 2018, Part 2: Rights of Private Sector Employees

DC Bar

Washington, DC

Speaker

Jun

2018

12th Annual ABA Civil False Claims Act and Qui Tam Enforcement National Institute

American Bar Association

Washington, DC

Moderator

May

2018

3rd Annual Mintz /ML Strategies Pharmacy & Pharmaceutical Industry Summit

Mintz and ML Strategies

Boston, MA

Speaker

Dec

2017

Compliance Programs and Internal Investigations in Health Care Organizations

Practicing Law Institute

New York, NY

Panelist

Jul

2017

Qui Tam Relators: What You Need to Know

Mintz Levin

Webinar

Speaker

Dec

2016

Health Care Law Institute 2016

PLI

New York, NY

Speaker

Oct

2016

Pharmacy Industry Enforcement Activity: Where We Are and Where We’re Headed

Webinar

Panelist

Jun

2016

ABA National Institute on the Civil False Claims Act and Qui Tam Enforcement

ABA

Washington, DC

Speaker

May

2016

Health Care Fraud National Institute

ABA

Indian Wells, CA

Moderator

Jan

2016

Advanced Compliance Education Webinar Series, Part IV: Compliance for Clinical Laboratories

American Health Lawyers Association

Webinar

Panelist

Jan

2016

Health Care Enforcement in 2016: A Look Back on 2015 and Forecasting the Year Ahead

Webinar

Speaker

Oct

2015

P3 Litigating a False Claims Act Case

Healthcare Enforcement Compliance Institute

Washington, DC

Mar

2015

ACI's 15th Advanced Forum on Fraud & Abuse in the Sales and Marketing of Drugs

American Conference Institute

Omni Parker House, Boston, MA

Read less

Best Lawyers in America: Health Care Law (2017-2025)
Included on the Washington DC Super Lawyers: Health Care list (2014-202, 2024)
Recognized by the The Legal 500 United States for Healthcare: Service Providers (2015)
US Attorney General’s Award for Exceptional Service (2000)
US Attorney General’s Award for Distinguished Service (1997)
DOJ Special Commendation for Outstanding Service (2003)
DOJ Special Achievement Awards (1997, 2000)
DOJ Meritorious Award (1996)
HHS Inspector General’s Exceptional Achievement Award (1997)
HHS Inspector General’s Integrity Award (1995)
National Association of Medicaid Fraud Control Units Award (1997, 2003)
Phi Beta Kappa
Chambers USA: District of Columbia – Healthcare (2019-2024)

Read less

Member, American Bar Association
Member, American Health Lawyers Association
BNA Health Care Fraud Report, Editorial Board Member
Rx Compliance Report, Advisory Board Member
Member, Board of Trustees, Temple Sinai (DC) 2018 - 2021
Sinai Assisted Housing Foundation, Board Member
Member, Program Committee, AdvaMed 2013

Read less

Unpacking Johnson & Johnson’s Lawsuit Over 340B Rebate Model

November 19, 2024| Blog|

FCA Settlements Demonstrate Importance of Cybersecurity Controls Imposed by Contract

August 20, 2024

The Best Lawyers in America 2025 Recognizes 184 Mintz Attorneys across 56 Practice Areas

Laurence J. Freedman

Member

Washington, DC New York

Experience

viewpoints

January 21, 2020 | Blog | By Brian Dunphy, Laurence Freedman, Karen Lovitch , Nicole Henry, Clare Prober

September 11, 2019 | Blog | By Samantha Kingsbury, Laurence Freedman, Brian Dunphy

June 25, 2019 | Blog | By Samantha Kingsbury, Laurence Freedman

June 4, 2019 | Blog | By Laurence Freedman, Daryl Berke

May 10, 2019 | Blog | By Jane Haviland, Laurence Freedman

February 4, 2019 | Blog | By Laurence Freedman, Daryl Berke

January 14, 2019 | Blog | By Laurence Freedman, Daryl Berke

January 11, 2019 | Blog | By Brian Dunphy, Laurence Freedman, Karen Lovitch

January 10, 2019 | Blog | By Brian Dunphy, Laurence Freedman

December 20, 2018 | Blog | By Laurence Freedman, Bridgette Keller

News & Press

August 20, 2024

August 15, 2024

June 06, 2024

April 22, 2024

August 17, 2023

June 01, 2023

March 18, 2023

December 14, 2022

November 1, 2022

August 18, 2022

June 01, 2022

August 27, 2021

August 19, 2021

May 20, 2021

August 20, 2020

April 24, 2020

April 16, 2020

January 29, 2020

January 15, 2020

August 15, 2019

May 6, 2019

April 26, 2019

April 23, 2019

February 25, 2019

August 15, 2018

April 27, 2018

April 24, 2018

January 26, 2018

January 25, 2018

January 18, 2018

August 15, 2017

June 16, 2017

April 24, 2017

January 18, 2017

January 17, 2017

December 29, 2016

December 12, 2016

October 31, 2016

September 7, 2016

August 15, 2016

July 3, 2016

June 30, 2016

June 17, 2016

June 17, 2016

June 03, 2016

May 26, 2016

April 25, 2016

April 11, 2016

March 28, 2016

February 26, 2016

February 11, 2016

January 26, 2016

January 25, 2016

January 22, 2016

January 2, 2016

October 21, 2015

June 11, 2015

April 17, 2015

March 12, 2015

May 14, 2014

April 25, 2014